Quick facts

Founding Year Team Members Headquarters
2013
Niel, Belgium
CEO Pipeline Other locations

Steven Powell       

Learn More     
  

7 preclinical projects    

1 clinical project

detailed pipeline

Ghent, Belgium

NY, New York, USA

Sheung Wan, Hong Kong

Therapeutic
Areas
Capitalization Founding
Investors

        Oncology        

Infectious
Diseases

EUR 63 million
in equity investment    

Series A financing
of EUR 24 million
in 2016

Series B financing
of EUR 39 million
mid-2020.

Vrije Universiteit
Brussel

Progress Pharma

Shareholders

Galileilaan 19, 2845 Niel, Belgium

Our Address

Our Mailbox

+32 3 369 17 40

Our Phone

© 2021 eTheRNA | Studio Hanswijk